Download the Free Unbound MEDLINE PubMed App to your smartphone or tablet.
Available for iPhone, iPad, iPod touch, and Android:
Available for Mac and Windows Desktops and laptops:
- Cessation of Primary Androgen Deprivation Therapy for Men With Localized Prostate Cancer. [JOURNAL ARTICLE]
- Clin Genitourin Cancer 2015 Mar 5.
- Loss of Wave1 gene defines a subtype of lethal prostate cancer. [JOURNAL ARTICLE]
- Oncotarget 2015 Mar 31.
- Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer. [JOURNAL ARTICLE]
- Cancer 2015 Apr 22.
- Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy. [JOURNAL ARTICLE]
- Oncotarget 2015 Apr 14.
- Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer. [Journal Article]
- J Am Heart Assoc 2015; 4(4)
- Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. [JOURNAL ARTICLE]
- Oncotarget 2015 Mar 26.
- Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. [JOURNAL ARTICLE]
- Am J Mens Health 2015 Apr 19.
- Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer. [Journal Article]
- BMC Urol 2015; 15(1):25.
- The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation. [JOURNAL ARTICLE]
- BMC Cancer 2015 Mar 27; 15(1):190.
- The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer. [Journal Article]
- Radiat Oncol 2015; 10(1):60.